The global Implantable Cardiac Rhythm Management (ICRM) Devices Market was valued at USD 15.87 billion in 2022 and is projected to reach USD 22.98 billion by 2032, with a rapid revenue CAGR of 4.2% during the forecast period. The market growth is primarily attributed to the increasing prevalence of Cardiovascular Diseases (CVDs) worldwide and the expanding geriatric population. Additionally,...